United States · FDA National Drug Code directory
Letrozole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 23155-875_40009527-770b-8999-e063-6294a90a9946
- Product NDC
- 23155-875
- Form
- TABLET, FILM COATED
- Composition / generic term
- Letrozole Tablets
- Labeler
- Avet Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230601
- Source listing expiry
- 20261231
Source-listed ingredients
- LETROZOLE — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (23155-875-03) · 23155-875-03
- 90 TABLET, FILM COATED in 1 BOTTLE (23155-875-09) · 23155-875-09
- 1000 TABLET, FILM COATED in 1 BOTTLE (23155-875-10) · 23155-875-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →